• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Surges Over 300 Points; US Inflation Rate Slows In May

    6/12/24 9:47:42 AM ET
    $BMR
    $GDHG
    $TCON
    $THMO
    Computer Software: Prepackaged Software
    Technology
    Services-Misc. Amusement & Recreation
    Consumer Discretionary
    Get the next $BMR alert in real time by email

    U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Wednesday.

    Following the market opening Wednesday, the Dow traded up 0.84% to 39,072.22 while the NASDAQ rose 0.87% to 17,494.72. The S&P 500 also rose, gaining, 0.84% to 5,420.33.

    Check This Out: General Motors, Toll Brothers And 2 Other Stocks Insiders Are Selling

    Leading and Lagging Sectors

    Real estate shares jumped by 2.1% on Wednesday.

    In trading on Wednesday, consumer staples shares rose by just 0.1%.

    Top Headline

    The annual CPI inflation rate fell from 3.4% to 3.3% in May, below than the median economist projection of 3.4%. According to Econoday, the economist consensus ranged from 3.3% to 3.5%.

    Equities Trading UP
                           

    • Golden Heaven Group Holdings Ltd. (NASDAQ:GDHG) shares shot up 51% to $0.2700.
    • Shares of Beamr Imaging Ltd. (NASDAQ:BMR) got a boost, surging 40% to $6.19 after the company announced that its Beamr Cloud solution has achieved Powered by Expertise and is now available in the Oracle Cloud Marketplace.
    • WANG & LEE GROUP, Inc. (NASDAQ:WLGS) shares were also up, gaining 29% to $0.78 after surging 16% on Tuesday.

    Equities Trading DOWN

    • Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares dropped 49% to $1.09. Tonix Pharmaceuticals priced its $4 million public offering of 3,753,558 shares of common stock at $1.065 per share.
    • Shares of ThermoGenesis Holdings, Inc. (NASDAQ:THMO) were down 39% to $0.3290 after the Nasdaq denied the company's request for continued listing and the stock will be suspended at the opening of business on June 17.
    • TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) was down, falling 28% to $0.78.

    Also Check This Out: Uber To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Wednesday

    Commodities

    In commodity news, oil traded up 1.1% to $78.79 while gold traded up 0.2% at $2,330.10.

    Silver traded up 1.9% to $29.495 on Wednesday, while copper rose 0.1% to $4.5150.

    Euro zone

    European shares were lower today. The eurozone's STOXX 600 gained 0.5%, Germany's DAX gained 0.6% and France's CAC 40 rose 0.5%. Spain's IBEX 35 Index rose 0.4%, while London's FTSE 100 rose 0.7%.

    German consumer price inflation increased to 2.4% in May from a three-year low of 2.2% in the prior month.

    The UK’s trade deficit increased to around two-year high of £6.75 billion in April, while British economy stalled during April following a 0.4% expansion in March. Industrial production in the UK fell 0.9% month-over-month for April.

    Asia Pacific Markets

    Asian markets closed mixed on Wednesday, with Japan's Nikkei falling 0.66%, Hong Kong's Hang Seng Index falling 1.31%, China's Shanghai Composite Index gaining 0.31% and India's S&P BSE Sensex gaining 0.20%.

    Total passenger vehicle sales in India rose 4.3% year-over-year to 300,795 in May following a 1.2% gain in the prior month. Producer prices in Japan rose 2.4% year-over-year in May compared to a revised 1.1% increase in April.

    Chinese annual inflation rate came in at 0.3% in May versus market estimates of 0.4%, while producer prices fell by 1.4% year-over-year in May.

    Economics

    • The annual CPI inflation rate fell from 3.4% to 3.3% in May, below than the median economist projection of 3.4%. According to Econoday, the economist consensus ranged from 3.3% to 3.5%.
    • On a monthly basis, the overall CPI inflation stalled, decelerating from the prior 0.3% growth and coming in below expectations of 0.1%.

    Now Read This: Top 2 Utilities Stocks That May Rocket Higher In June

    Get the next $BMR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BMR
    $GDHG
    $TCON
    $THMO

    CompanyDatePrice TargetRatingAnalyst
    Tonix Pharmaceuticals Holding Corp.
    $TNXP
    4/18/2022Outperform
    Noble Capital Markets
    TRACON Pharmaceuticals Inc.
    $TCON
    2/23/2022$10.00Outperform
    Baird
    More analyst ratings

    $BMR
    $GDHG
    $TCON
    $THMO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit

    TONMYA demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT study Unique sublingual formulation designed for bedtime dosing bypasses first-pass metabolism, optimizing parent-drug exposure during sleep and decreasing levels of the persistent active metabolite Treatment was well tolerated with minimal effects on weight or blood pressure CHATHAM, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix" or the "Company"), a fully integrated, commercial biotechnology company, presented data on TONMYA™, which was investigated as TNX-102 SL, at the 2026 Non-Opioid Pain Therapeutics Summit, on January 29

    1/30/26 7:00:00 AM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Beamr to Showcase Validation of Video Workflows Powered by NVIDIA

    Company to participate at Mile High Video 2026, from February 2-5, 2026 in Denver, ColoradoHerzliya, Israel, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ:BMR), a leader in video optimization technology and solutions, will showcase a validation framework that verifies how compressed and AI-enhanced video preserves quality as human viewers perceive it, at Mile High Video 2026, February 2-5, 2026 in Denver, Colorado. As Ultra HD becomes the baseline for consumer viewing and AI-enhanced video workflows gain traction, streaming platforms and broadcasters face a critical verification challenge: proving that AI-enhanced and compressed video offers the visual quality viewers expe

    1/28/26 7:10:00 AM ET
    $BMR
    Computer Software: Prepackaged Software
    Technology

    Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026

    BERKELEY HEIGHTS, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix or the Company), a fully integrated, commercial biotechnology company, announced today that Tonix management will present and host investor meetings at the following January 2026 investor conferences. Sachs Associates 9th Annual Neuroscience Innovation Forum Company Presentation Presenter: Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals Date: Sunday, January 11, 2026 Place: Marines' Memorial Club & Hotel, San Francisco, Calif. Time: 11:55 a.m. PTRoom: Track A, Rosenberg Room Sachs Associates 9th Annual Neuroscience Innovation ForumPanel Pa

    1/6/26 7:00:00 AM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMR
    $GDHG
    $TCON
    $THMO
    SEC Filings

    View All

    SEC Form EFFECT filed by Golden Heaven Group Holdings Ltd.

    EFFECT - GOLDEN HEAVEN GROUP HOLDINGS LTD. (0001928340) (Filer)

    2/9/26 12:15:16 AM ET
    $GDHG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Tonix Pharmaceuticals Holding Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events

    8-K - Tonix Pharmaceuticals Holding Corp. (0001430306) (Filer)

    2/3/26 7:00:44 AM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form F-3/A filed by Golden Heaven Group Holdings Ltd.

    F-3/A - GOLDEN HEAVEN GROUP HOLDINGS LTD. (0001928340) (Filer)

    2/2/26 4:15:25 PM ET
    $GDHG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $BMR
    $GDHG
    $TCON
    $THMO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Taylor Carolyn E. bought $15,061 worth of shares (418 units at $36.03) (SEC Form 4)

    4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)

    8/21/25 5:22:56 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Treco James bought $9,000 worth of shares (250 units at $36.00) (SEC Form 4)

    4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)

    8/20/25 4:15:15 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Hunter James Randolph Jr

    4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)

    6/13/25 4:42:46 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMR
    $GDHG
    $TCON
    $THMO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Taylor Carolyn E. bought $15,061 worth of shares (418 units at $36.03) (SEC Form 4)

    4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)

    8/21/25 5:22:56 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Treco James bought $9,000 worth of shares (250 units at $36.00) (SEC Form 4)

    4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)

    8/20/25 4:15:15 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Lederman Seth bought $86,200 worth of shares (4,000 units at $21.55), increasing direct ownership by 80,000% to 4,005 units (SEC Form 4)

    4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)

    5/15/25 5:08:40 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMR
    $GDHG
    $TCON
    $THMO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Noble Capital Markets initiated coverage on Tonix Pharma

    Noble Capital Markets initiated coverage of Tonix Pharma with a rating of Outperform

    4/18/22 9:20:45 AM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Baird initiated coverage on TRACON Pharmaceuticals with a new price target

    Baird initiated coverage of TRACON Pharmaceuticals with a rating of Outperform and set a new price target of $10.00

    2/23/22 4:50:05 AM ET
    $TCON
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Alliance Global Partners initiated coverage on TRACON Pharmaceuticals with a new price target

    Alliance Global Partners initiated coverage of TRACON Pharmaceuticals with a rating of Buy and set a new price target of $13.00

    6/4/21 8:08:23 AM ET
    $TCON
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BMR
    $GDHG
    $TCON
    $THMO
    Leadership Updates

    Live Leadership Updates

    View All

    Tonix Pharmaceuticals Appoints Irina Ishak as General Counsel

    CHATHAM, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix" or the "Company"), a fully integrated commercial-stage biotechnology company today announced the appointment of Irina Ishak as General Counsel, effective December 8, 2025. Ms. Ishak will lead Tonix's legal, corporate governance, and compliance functions. "Irina is a highly accomplished corporate and commercial attorney whose experience spans public and private life sciences companies, as well as advising life sciences investors," said Seth Lederman, M.D., President and Chief Executive Officer of Tonix. "Her deep background in complex transactions, public company matters, and governa

    12/9/25 7:00:00 AM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tonix Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Highlights

    Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia set to launch in November Tonmya is the first new FDA-approved medicine for fibromyalgia in more than 15 years Cash and cash equivalents of $190.1 million reported as of September 30, 2025; current cash runway expected to fund operations into the first quarter of 2027 CHATHAM, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix" or the "Company"), a fully-integrated commercial biotechnology company today announced financial results for the third quarter ended September 30, 2025, and provided an overview of recent operational highlights. "Following U.S. Food a

    11/10/25 4:15:00 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kamath as Head of Market Access

    Mr. Kamath brings more than 25 years of market access, pricing, and commercial operations experience to Tonix On August 15, 2025, the U.S. Food and Drug Administration approved Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, the first new fibromyalgia therapy in more than 15 years US Launch of Tonmya expected in the fourth quarter of 2025 CHATHAM, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix" or the "Company"), a fully-integrated biotechnology company with marketed products and a pipeline of development candidates, today announced the appointment of Ganesh Kamath as Head of Market Access

    9/30/25 8:30:00 AM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMR
    $GDHG
    $TCON
    $THMO
    Financials

    Live finance-specific insights

    View All

    Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia

    Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years Fibromyalgia is a chronic pain condition that affects more than 10 million adults in the U.S. who are mostly women Two Pivotal Phase 3 studies demonstrated Tonmya significantly reduced fibromyalgia pain compared to placebo; generally well tolerated Commercial availability of Tonmya is expected in the fourth quarter Company to host webcast and conference call on Monday August 18, 2025 at 8:30 AM ET CHATHAM, N.J., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a fully-integrated biotechnology company, today announced that the U.S. Food and Drug Administratio

    8/15/25 3:44:52 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    WANG & LEE'S INNOVATIVE CRYPTO DIVIDEND STRATEGY: PROTECTING SHAREHOLDERS

    Hong Kong, March 12, 2025 (GLOBE NEWSWIRE) -- As disclosed in a press release dated March 4, 2025, Wang & Lee Group, Inc. (NASDAQ:WLGS), intends to distribute a cryptocurrency dividend to its shareholders upon realizing profits and subject to there being retained earnings according to the Company's audited financial statements. The Company's decision to explore a crypto dividend reflects its commitment to embracing cutting-edge financial technologies and delivering value to its shareholders in innovative ways. Wang & Lee's crypto dividend initiative is designed not only to reward shareholders but also to safeguard their interests by addressing potential market abuses such as naked short

    3/12/25 11:42:00 AM ET
    $WLGS
    Engineering & Construction
    Consumer Discretionary

    Wang & Lee pays Crypto Dividends to Destroy Dishonest Naked Short Sellers and Protect Shareholders

    Hong Kong, March 04, 2025 (GLOBE NEWSWIRE) -- Wang & Lee Group (NASDAQ:WLGS) today announced a groundbreaking milestone, Makes Legendary History as first Hong Kong Company to distribute shareholder dividends using cryptocurrency mined exclusively through its solar battery crypto farms. This bold initiative underscores the company's leadership in merging renewable energy solutions with cutting-edge blockchain technology, setting a new standard for sustainable corporate practices. A Visionary Leap Toward Sustainability Wang & Lee Group's dividend payment leverages cryptocurrency mined via its proprietary solar battery crypto farms, which harness excess clean energy generated during peak pr

    3/4/25 9:30:00 AM ET
    $WLGS
    Engineering & Construction
    Consumer Discretionary

    $BMR
    $GDHG
    $TCON
    $THMO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by TRACON Pharmaceuticals Inc.

    SC 13G/A - Tracon Pharmaceuticals, Inc. (0001394319) (Subject)

    11/14/24 8:51:58 PM ET
    $TCON
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Tonix Pharmaceuticals Holding Corp.

    SC 13G/A - Tonix Pharmaceuticals Holding Corp. (0001430306) (Subject)

    11/14/24 4:42:22 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Tonix Pharmaceuticals Holding Corp.

    SC 13G/A - Tonix Pharmaceuticals Holding Corp. (0001430306) (Subject)

    11/14/24 4:40:17 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care